MoneyWorks4Me

Lactose India informs about board meeting

19 Jan 2019 Evaluate

Lactose India has informed that  the meeting of the Board of Directors of the Company is scheduled on 25/01/2019, to consider and approve the appointment of  Mahendrakumar Singhi Omprakash (DIN:00369418) as an Additional Independent Director of the company; the re-appointment of Sangita Maheshwari (DIN: 00369898) as the Whole-time Director of the Company; and other business with the permission of chair.

The above information is a part of company’s filings submitted to BSE.

Lactose (India) Share Price

107.45 1.90 (1.80%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: